David Veitch has been named president of Savient Europe, effective January 16, 2012. Mr. Veitch has extensive commercial knowledge of the EU across marketing, sales, market access and general management. Mr. Veitch will report directly to John H. Johnson, chief executive officer and president of parent company Savient Pharmaceuticals. He will be responsible for establishing, building and leading the company’s European regional organization to launch and drive the future growth of gout treatment ...